Field Story
2022: celebrating milestones, innovations and making a difference globally
December 30, 2022
This brief summarizes the results and implications of new evidence around WHO recommended WIFAS containing 2.8 mg folic acid and its association with a lower risk of neural tube defects than the current practice of 0.4 mg folic acid. Including the WHO-recommended WIFAS dose on the WHO model EML could improve its availability and affordability for use in WIFAS programs by guiding national EMLs and thus purchasing and supply management decisions.